Analystreport

Oncolytics Biotech Inc. (NASDAQ: ONCY) is now covered by analysts at Raymond James. They set an "outperform" rating and a $3.00 price target on the stock.

Oncolytics Biotech Inc. - Common Shares  (ONCY) 
Last oncolytics biotech inc. - common shares earnings: 11/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.oncolyticsbiotech.com